Free Trial
NASDAQ:MCTA

Charming Medical (MCTA) Stock Price, News & Analysis

Charming Medical logo
$29.36 0.00 (0.00%)
As of 11/13/2026

About Charming Medical Stock (NASDAQ:MCTA)

Advanced

Key Stats

Today's Range
$29.36
▼
$29.36
50-Day Range
$29.36
▼
$29.36
52-Week Range
$4.30
▼
$31.70
Volume
N/A
Average Volume
N/A
Market Capitalization
$504.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Charming Medical Limited is a China-based provider of medical aesthetic services. The company operates medical institutions that offer treatments and procedures in the medical aesthetics field.

Publicly available information about the company’s specific service offerings, operating locations and leadership is limited, so further details cannot be confirmed.

AI Generated. May Contain Errors.

Receive MCTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Charming Medical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MCTA Stock News Headlines

Today's free pick (on me)
Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th.tc pixel
Charming Medical Stock Price History
See More Headlines

MCTA Stock Analysis - Frequently Asked Questions

Charming Medical's stock was trading at $29.36 on January 28, 2026. Since then, MCTA shares have decreased by 0.0% and is now trading at $29.3550.

Charming Medical (MCTA) raised $8 million in an IPO on Tuesday, October 21st 2025. The company issued 1,600,000 shares at a price of $4.00-$6.00 per share.

Shares of MCTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
11/14/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Diversified Consumer Services
Sub-Industry
Specialized Consumer Services
Current Symbol
NASDAQ:MCTA
CIK
2035992
Fax
N/A
Employees
49
Year Founded
2024

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.89
Quick Ratio
1.88

Sales & Book Value

Annual Sales
$4.81 million
Price / Sales
104.85
Cash Flow
$0.01 per share
Price / Cash Flow
2,571.55
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
17,180,000
Free Float
N/A
Market Cap
$504.32 million
Optionable
N/A
Beta
N/A
Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:MCTA) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners